The integration of AI has transformed the way eye diseases are diagnosed and even predicted🤯...
𝐒𝐢𝐠𝐡𝐭 𝐒𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐋𝐚𝐮𝐧𝐜𝐡𝐞𝐬 𝐎𝐌𝐍𝐈 𝐄𝐝𝐠𝐞 𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐒𝐲𝐬𝐭𝐞𝐦
👀 Sight Sciences has introduced the OMNI® Edge Surgical System at ASCRS 2025, a next-generation device for minimally invasive glaucoma surgery (MIGS). Building on the original OMNI platform, OMNI Edge features TruSync™ technology for precise viscoelastic delivery and an increased capacity of up to 21 µL. Designed to target all three resistance points in aqueous outflow, it offers an implant-free, versatile solution for treating primary open-angle glaucoma. The system is now available in the U.S.
